Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Zeria Pharmaceutical Co. Ltd.
DescriptionOral cholecystokinin B (CCK2) receptor antagonist
Molecular Target Cholecystokinin B receptor (CCKBR) (CCK2R)
Mechanism of ActionCholecystokinin receptor antagonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationPancreatic cancer
Indication DetailsTreat pancreatic cancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today